Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Timber Pharmaceuticals, Inc. | tm2021863d1_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - Timber Pharmaceuticals, Inc. | tm2021863d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Timber Pharmaceuticals, Inc. | tm2021863d1_ex31-1.htm |
| 10-Q - FORM 10-Q - Timber Pharmaceuticals, Inc. | tm2021863d1_10q.htm |
Exhibit 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, John Koconis, Chief Executive Officer of Timber Pharmaceuticals, Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
| 1. | The Quarterly Report on Form 10-Q of the Company for the period ended April 30, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and |
| 2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein. |
| Date: June 12, 2020 | ||
| /s/ John Koconis | ||
| John Koconis | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) |